Financhill
Sell
43

ABUS Quote, Financials, Valuation and Earnings

Last price:
$3.18
Seasonality move :
17.75%
Day range:
$3.10 - $3.26
52-week range:
$2.71 - $4.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
93.75x
P/B ratio:
7.67x
Volume:
1.1M
Avg. volume:
800.7K
1-year change:
-9.69%
Market cap:
$607.1M
Revenue:
$6.2M
EPS (TTM):
-$0.41

Earnings Data

Next earnings date for ABUS
Aug 01
2025
Most recent earnings per share
-$0.13
Missed by $0.02
(May 14/2025)
Consensus Estimate
-$0.11
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ABUS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $1.6M -- -- -$0.06 --
08/01/2025 Q2 $1.6M -- -- -$0.07 --
05/14/2025 Q1 $1.6M $1.8M -$0.13 -$0.11 -$0.02
03/27/2025 Q4 $1.5M $1.6M -$0.07 -$0.08 $0.01
11/06/2024 Q3 $1.9M $1.3M -$0.10 -$0.09 -$0.01
08/01/2024 Q2 $1.8M $1.7M -$0.11 -$0.10 -$0.01
05/02/2024 Q1 $2.7M $1.5M -$0.10 -$0.11 $0.01
02/29/2024 Q4 $4.9M $2.1M -$0.12 -$0.12 -$0.00
11/07/2023 Q3 $4.7M $4.7M -$0.12 -$0.11 -$0.01
08/03/2023 Q2 $6.2M $4.7M -$0.10 -$0.11 $0.01
05/04/2023 Q1 $6M $6.7M -$0.10 -$0.13 $0.03
03/02/2023 Q4 -- $6.2M -$0.14 -- --
11/09/2022 Q3 -- $6M -$0.12 -- --
08/04/2022 Q2 -- $14.2M -$0.10 -- --
05/05/2022 Q1 -- $12.6M -$0.11 -- --
03/03/2022 Q4 -- $3.2M -$0.15 -- --
11/04/2021 Q3 -- $3.3M -$0.24 -- --
08/05/2021 Q2 -- $2.3M -$0.23 -- --
05/05/2021 Q1 -- $2.1M -$0.21 -- --
03/04/2021 Q4 -- $2.4M -$0.23 -- --
11/05/2020 Q3 -- $1.5M -$0.27 -- --
08/07/2020 Q2 -- $1.5M -$0.25 -- --
05/11/2020 Q1 -- $1.5M -$0.25 -- --
03/05/2020 Q4 -- $1.6M -$0.46 -- --
11/06/2019 Q3 -- $3.1M -$1.50 -- --
08/05/2019 Q2 -- $653K -$0.46 -- --
05/06/2019 Q1 -- $679K -$0.47 -- --
03/07/2019 Q4 -- $1.7M -$0.37 -- --
11/07/2018 Q3 -- $1.6M -$0.49 -- --
08/02/2018 Q2 -- $1.2M $0.01 -- --
05/03/2018 Q1 -- $1.4M -$0.36 -- --
03/14/2018 Q4 -- $2.5M -$0.67 -- --
11/02/2017 Q3 -- $6.9M -$0.21 -- --
08/03/2017 Q2 -- $1M -$0.33 -- --
05/04/2017 Q1 -- $235K -$0.34 -- --
03/21/2017 Q4 -- -$195K -$4.09 -- --
09/30/2016 Q3 -- $774K -$0.37 -- --
06/30/2016 Q2 -- $309K -$2.47 -- --
03/31/2016 Q1 -- $603K -$0.31 -- --
12/31/2015 Q4 -- $11.1M -$0.10 -- --
09/30/2015 Q3 -- $4.1M -$0.57 -- --

Arbutus Biopharma Earnings Questions

  • How Much did Arbutus Biopharma Generate in Revenue Last Quarter?

    Arbutus Biopharma reported $1.8M worth of top line sales in its most recent quarter.

  • Did Arbutus Biopharma Beat Earnings Last Quarter?

    Arbutus Biopharma announced earnings per share of -$0.13 which represents a miss of analyst forecast a -$0.11 per share.

  • Is Arbutus Biopharma Profitable?

    Arbutus Biopharma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Arbutus Biopharma EPS Next Year?

    Arbutus Biopharma's earnings are forecast to decrease from -$0.38 per share to -$0.38 per share next year representing a decrease of -18.27%.

  • When is Arbutus Biopharma's Earnings Date?

    Arbutus Biopharma's next earnings date is August 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 14

MiNK Therapeutics [INKT] is down 38.37% over the past day.

Buy
51
NEGG alert for Jul 14

Newegg Commerce [NEGG] is down 33.69% over the past day.

Buy
68
ATRO alert for Jul 14

Astronics [ATRO] is down 2.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock